Associations Between Matrix Metalloproteinase-8 and -14 and Myeloperoxidase in Gingival Crevicular Fluid From Subjects With Progressive Chronic Periodontitis: A Longitudinal Study
Artículo
Open/ Download
Publication date
2010-11Metadata
Show full item record
Cómo citar
Hernández Ríos, Emma
Cómo citar
Associations Between Matrix Metalloproteinase-8 and -14 and Myeloperoxidase in Gingival Crevicular Fluid From Subjects With Progressive Chronic Periodontitis: A Longitudinal Study
Author
Abstract
Background: Matrix metalloproteinase (MMP)-8 is a central
mediator in chronic periodontitis. MMP-8 can be activated by
the cooperative action of otherMMPs such asMMP-14, reactive
oxygen species, andmicrobial proteases. The aimof this study
is to associate the levels, molecular forms, isoenzyme distribution,
and degree of activation of MMP-8 and -14, myeloperoxidase
(MPO), and tissue inhibitor of MMP (TIMP)-1 in gingival
crevicular fluid (GCF) from patients with progressive periodontitis
at baseline and after periodontal therapy.
Methods: In this longitudinal study, GCF samples from active
(n = 25) and inactive (n = 25) sites of subjects with periodontitis
were screened at baseline for GCF levels of MMP-8 by immunofluorometric
assay, of MMP-14 by specific activity assay, and of
MPOandTIMP-1 by enzyme-linked immunosorbent assay.MMP-8
andMPOwere alsomeasuredafterperiodontal treatment. Molecular
forms were determined by immuno-Western blot analyses
and subjected to densitometric scanning and statistical analyses.
Results: High MMP-8 and MPO levels and a strong MPO/
MMP-8 positive correlation were found in active and inactive
sites at baseline. After treatment, decreases in MPO and
MMP-8 were seen, except for active sites in which MMP-8 differences
were not significant (P <0.05).
Conclusions: We present initial data that show that GCF
levels and associations between MPO and MMP-8 are related
to progression episodes and treatment responses in patients
with chronic periodontitis. Our results suggest an interaction between
the MPO oxidative pathway and MMP-8 activation, and
this cascade might be useful as a potential biomarker for treatment
outcomes.
Patrocinador
This study was supported by grants from theAcademy
of Finland, Helsinki (1130408), the Research Foundation
of the Helsinki University Central Hospital (TYH
2010208), and from the Scientific and Technologic
Investigation Resource, Santiago, Chile (1090461).
The authors thank Maiju Kivisto¨, secretary, and Ritva
Keva, laboratory technician, Institute of Dentistry,
University of Helsinki, Helsinki, Finland, for secretarial
and technical help, respectively. Dr. Sorsa is an inventor
of United States patents 5652223, 5736341,
5866432, and 6143476. All other authors report no
conflicts of interest related to this study.
Identifier
URI: https://repositorio.uchile.cl/handle/2250/123407
DOI: doi:10.1902/jop.2010.100196
ISSN: 0022-3492
Quote Item
J Periodontol. 2010 Nov;81(11):1644-52.
Collections